Valuation: TAUNS Laboratories,Inc.

Market Cap 4.98TCr 32Cr 28Cr 26Cr 24Cr 45Cr 3.03TCr 45Cr 304.06Cr 119.08Cr 1.51TCr 119.37Cr 116.73Cr P/E 2025
8.67x
P/E 2026 * 9.39x
Enterprise Value 5.67TCr 36Cr 31Cr 29Cr 27Cr 51Cr 3.44TCr 52Cr 345.73Cr 135.41Cr 1.72TCr 135.74Cr 132.73Cr EV / Sales 2025
3.23x
EV / Sales 2026 * 3.92x
Free-Float
29.89%
Yield 2025
5.2%
Yield 2026 * 7.55%
1 day-0.43%
1 week-1.69%
Current month-1.69%
1 month-0.43%
3 months-8.28%
6 months-13.89%
Current year-8.64%
1 week 465
Extreme 465
482
1 month 464
Extreme 464
493
Current year 463
Extreme 463
568
1 year 463
Extreme 463
603
3 years 401
Extreme 401
733
5 years 401
Extreme 401
733
10 years 401
Extreme 401
733
Manager TitleAgeSince
Chief Executive Officer 51 01/05/2014
Director of Finance/CFO 66 01/11/2018
Corporate Officer/Principal 39 01/07/2022
Director TitleAgeSince
Director/Board Member 51 01/05/2014
Director/Board Member 66 01/09/2020
Director/Board Member 53 01/04/2016
Change 5-day change 1-year change 3-year change Capi.($)
-0.43%-1.69%-11.93% - 32Cr
-1.95%+9.18%+283.46%+346.90% 2.13TCr
+0.83%-2.94%-42.03%-23.06% 978.4Cr
+1.56%-6.33%+43.39%+38.50% 658.81Cr
-0.55%+2.37%+259.40%-19.63% 596.82Cr
+0.17%+2.09%-11.61%-15.66% 557.65Cr
+4.15%+4.41%-41.80% - 461.33Cr
-1.06%+5.30%-12.52%-21.89% 458.35Cr
-5.57%-10.70%+65.05%+81.04% 401.34Cr
+3.20%+7.08%-14.64%-35.31% 289.01Cr
Average -0.12%+2.59%+51.68%+43.86% 656.49Cr
Weighted average by Cap. -0.53%+4.18%+112.18%+120.89%

Financials

2025 2026 *
Net sales 1.91TCr 12Cr 11Cr 9.86Cr 9.06Cr 17Cr 1.16TCr 17Cr 116.32Cr 46Cr 577.88Cr 46Cr 45Cr 1.48TCr 9.41Cr 8.18Cr 7.64Cr 7.01Cr 13Cr 897.11Cr 13Cr 90Cr 35Cr 447.38Cr 35Cr 35Cr
Net income 649.96Cr 4.15Cr 3.6Cr 3.36Cr 3.09Cr 5.82Cr 395.15Cr 5.92Cr 40Cr 16Cr 197.05Cr 16Cr 15Cr 520.13Cr 3.32Cr 2.88Cr 2.69Cr 2.47Cr 4.66Cr 316.22Cr 4.74Cr 32Cr 12Cr 157.7Cr 12Cr 12Cr
Net Debt 682.93Cr 4.36Cr 3.79Cr 3.53Cr 3.24Cr 6.12Cr 415.2Cr 6.22Cr 42Cr 16Cr 207.05Cr 16Cr 16Cr 799.4Cr 5.1Cr 4.43Cr 4.14Cr 3.8Cr 7.16Cr 486.01Cr 7.29Cr 49Cr 19Cr 242.36Cr 19Cr 19Cr
Logo TAUNS Laboratories,Inc.
Tauns Laboratories Inc is a Japan-based company engaged in the business of developing, manufacturing and marketing in vitro diagnostic products and research reagents. The Company operates its business in the in vitro diagnostic products business segment. The Company’s main product is antigen test kit that uses immunochromatography to enable rapid diagnosis at the patient's side without the need for special equipment. The products include ImunoAce Flu, ImunoAce SARSCoV-2 II, ImunoAce SARSCoV-2 Saliva, ImunoAce SARSCoV-2/Flu, ImunoAce Adeno, ImunoAce Strep A Neo, ImunoAce hMPV, ImunoAce Mycopiasma, ImunoAce RSV Neo and ImunoAce Noro.
Employees
218
Date Price Change Volume
04/26/04 JP¥465.00 -0.43% 2,20,100
03/26/03 JP¥467.00 -1.27% 5,08,200
31/26/31 JP¥473.00 -0.63% 2,52,800
30/26/30 JP¥476.00 -1.24% 2,21,800
29/26/29 JP¥482.00 +1.90% 4,29,400
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
467.00JPY
Average target price
420.00JPY
Spread / Average Target
-10.06%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 197A Stock